arrow
Back
I

Ichiro Nakashima

Tohoku Medical and Pharmaceutical University

70H-index
570Paper Count
2.3WCitation Count
Published Papers 129
Publication Date
DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammation
err2026-05-29
err0
errOAAI
errAtsushi Fujioka; Kenji Shimizu; Saki Nakayama; Dai Ueno; Yuki Chiba; Ichiro Nakashima; Juichi Fujimori; Yuko Shirota; Yoichiro Iwakura; Yasushi Muraki; Akira Nakamura; Tomonori Kaifu
errShare
errSave
Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study
err2026-03-26
err0
PREAI
errHiroki Masuda; Akiyuki Uzawa; Mamoru Shibata; Masahiro Mori; Yusei Miyazaki; Masaaki Niino; Juichi Fujimori; Ichiro Nakashima; Yoshiki Takai; Naoya Yamazaki; Tatsuro Misu; Makoto Kinoshita; Tatsusada Okuno; Koji Sekiguchi; Jin Nakahara; Hajime Takeuchi; Keisuke Mizutani; Ayano Matsuyoshi; Yuu-ichi Kira; Kazunori Iwao; Eizo Tanaka; Koji Shinoda; Mitsuru Watanabe; Katsuhisa Masaki; Noriko Isobe; Mayumi Muto; Ryohei Ohtani; Shinji Aoyama; Sonoko Misawa; Kazumoto Shibuya; Tomoki Suichi; Manato Yasuda; Yuya Aotsuka; Marie Morooka; Ryo Otani; Yosuke Onishi; Hiroyuki Akamine; Hideo Handa; Etsuko Ogaya; Moeko Ogushi; Kentaro Kurumada; Satoshi Kuwabara
errShare
errSave
Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study)
err2026-02-24
err0
PREAI
errKazuo Fujihara; Noriko Isobe; Katsuichi Miyamoto; Masaaki Niino; Jin Nakahara; Satoshi Hattori; Masami Tanaka; Masayuki Tahara; Akio Suzumura; Kenzo Sakurai; Nobuaki Yoshikura; Kazutaka Shiomi; Hirofumi Ochi; Eiichiro Nagata; Kazushi Deguchi; Yuji Tomizawa; Katsuhisa Yamashita; Tadashi Nagatsuka; Hiroki Adachi; Ichiro Nakashima
errShare
errSave
A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: the REFIND study
err2026-01-15
err0
errOAAI
errIchiro Nakashima; Takashi Ohashi; Kazumasa Yokoyama; Kenichi Kaida; Jin Nakahara; Takayuki Kondo; Nobuaki Yoshikura; Yuko Shimizu; Chiyoko Nohara; Kenzo Sakurai; Hiroaki Yokote; Masaaki Niino; Takashi Yamamura; Kazuo Fujihara; Noriko Isobe; Hirofumi Ochi; Masahiro Mori; Izumi Kawachi; Fumitaka Shimizu; Michihiro Kanda
errShare
errSave
Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2-Year Post-Marketing Surveillance Data
err2025-12-01
err0
errOAAI
errOchi, Hirofumi; Fukazawa, Toshiyuki; Yamamura, Takashi; Yokoyama, Kazumasa; Ohashi, Takashi; Nakashima, Ichiro; Mizuno, Masanori; Fukaura, Hikoaki; Kawachi, Izumi; Okuno, Tatsusada; Sato, Ryusuke; Makioka, Haruki; Tsuchiya, Aya; Kanda, Michihiro; Sato, Yayoi; Saida, Takahiko
errShare
errSave
Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis
err2025-11-21
err0
errOAAI
errFujimori, Juichi; Nei, Michiko; Umezawa, Shu; Misu, Tatsuro; Nakashima, Ichiro
errShare
errSave
Venglustat in GM2 Gangliosidoses and Related Disorders: Results of the AMETHIST Randomized Controlled and Basket Trials
err2025-10-15
err0
errOAAI
errCynthia J. Tifft; Isabela Batsu; Roberto Giugliani; Harmonie Goyeau; Andreas Hahn; Simon A. Jones; Pascal Minini; Ichiro Nakashima; Mar O’Callaghan; Susan Perlman; Nathan Thibault; Madhurima Uppara Kowthalam; Riliang Zheng; Timothy M. Cox
errShare
errSave
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance
err2025-09-26
err0
errOAAI
errTakashi Yamamura; Noriko Isobe; Izumi Kawachi; Chiyoko Nohara; Yusei Miyazaki; Minami Tomita; Yuta Kamei; Katsuhisa Yamashita; Jin Nakahara; Ichiro Nakashima; Kazuo Fujihara
errShare
errSave
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review
err2025-06-01
err0
PREAI
errFujihara, Kazuo; Isobe, Noriko; Miyamoto, Katsuichi; Niino, Masaaki; Nakahara, Jin; Hattori, Satoshi; Yamamoto, Mamoru; Kawachii, Izumi; Matsui, Naoko; Nohara, Chiyoko; Kokubun, Norito; Chihara, Norio; Misu, Tatsuro; Okada, Kazumasa; Yamashita, Katsuhisa; Nagatsuka, Tadashi; Adachi, Hiroki; Nakashima, Ichiro
errShare
errSave
CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease
err2025-04-11
err0
errOAAI
errOno, Hirohiko; Misu, Tatsuro; Namatame, Chihiro; Matsumoto, Yuki; Takai, Yoshiki; Nishiyama, Shuhei; Kuroda, Hiroshi; Takahashi, Toshiyuki; Nakashima, Ichiro; Fujihara, Kazuo; Aoki, Masashi
errShare
errSave
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD
err2024-09-01
err2
errOAAI
errKaneko, Kimihiko; Kuroda, Hiroshi; Matsumoto, Yuki; Sakamoto, Naohiro; Yamazaki, Naoya; Yamamoto, Naoki; Umezawa, Shu; Namatame, Chihiro; Ono, Hirohiko; Takai, Yoshiki; Takahashi, Toshiyuki; Fujimori, Juichi; Nakashima, Ichiro; Harigaya, Yasuo; Lassmann, Hans; Fujihara, Kazuo; Misu, Tatsuro; Aoki, Masashi
errShare
errSave
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance
err2024-07-16
err2
errOAAI
errYamamura, Takashi; Isobe, Noriko; Kawachi, Izumi; Nohara, Chiyoko; Miyazaki, Yusei; Tomita, Minami; Tsumuraya, Takahiko; Yamashita, Katsuhisa; Nakahara, Jin; Nakashima, Ichiro; Fujihara, Kazuo
errShare
errSave
Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
err2023-12-01
err0
PREAI
errPittock, Sean; Barnett, Michael; Bennett, Jeffrey; Berthele, Achim; De Seze, Jerome; Levy, Michael; Nakashima, Ichiro; Oreja-Guevara, Celia; Palace, Jacqueline; Paul, Friedemann; Pozzilli, Carlo; Allen, Kerstin; Mashhoon, Yasmin; Yountz, Marcus; Kim, Ho Jin
errShare
errSave
Eculizumab in AQP4+neuromyelitis optica spectrum disorder: 3 years of data from Japanese post-marketing surveillance
err2023-12-01
err0
PREAI
errNakahara, Jin; Nakashima, Ichiro; Yokote, Hiroaki; Manabe, Yasuhiro; Okamura, Kazumi; Hasegawa, Kou; Fujihara, Kazuo
errShare
errSave
Associations between neuromyelitis optica spectrum disorder, Sjo•gren's syndrome, and conditions with electrolyte disturbances
err2023-09-01
err5
PREAI
errAkaishi, Tetsuya; Tarasawa, Kunio; Matsumoto, Yuki; Sandhya, Pulukool; Misu, Tatsuro; Fushimi, Kiyohide; Takahashi, Toshiyuki; Fujimori, Juichi; Ishii, Tadashi; Fujimori, Kenji; Yaegashi, Nobuo; Nakashima, Ichiro; Fujihara, Kazuo; Aoki, Masashi
errShare
errSave
A case of Balo's concentric sclerosis showing the attenuation of the Balo lesion after ofatumumab treatment: A case report
err2023-07-01
err0
errOAAI
errSuzuki, Daisuke; Suzuki, Yoshihiro; Sato, Daisuke; Kikuchi, Kenji; Akasaka, Masahiro; Nishida, Akiko; Sato, Kazuhiko; Koyama, Shingo; Nakashima, Ichiro; Ohta, Yasuyuki
errShare
errSave
Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder During the Phase 3 CHAMPION-NMOSD trial
err2023-04-25
err0
PREAI
errOrtiz, Stephan; Pittock, Sean; Berthele, Achim; Levy, Michael; Nakashima, Ichiro; Guevara, Celia Oreja; Kim, Ho Jin
errShare
errSave
Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: outcomes from the phase 3 CHAMPION-NMOSD trial
err2023-04-25
err0
PREAI
errPittock, Sean; Barnett, Michael; Bennett, Jeffrey; Berthele, Achim; De Seze, Jerome; Levy, Michael; Nakashima, Ichiro; Guevara, Celia Oreja; Palace, Jacqueline; Paul, Friedemann; Pozzilli, Carlo; Allen, Kerstin; Mashhoon, Yasmin; Yountz, Marcus; Kim, Ho Jin
errShare
errSave